Trial Profile
Consultant in Nephrology. MD., Ph.D.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 May 2017
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Proteinuria; Renal fibrosis
- Focus Therapeutic Use
- 03 May 2017 Primary endpoint (Change in albumin/creatinine ratio from baseline to end of study) has not been met, according to the results presented at the 2017 American Transplant Congress
- 03 May 2017 Results presented at the 2017 American Transplant Congress
- 03 May 2017 New trial record